Get the latest Virpax Pharmaceuticals earnings report, revenues as well as upcoming VRPX earnings dates, historical financial reports, news, analysis & more. ... there has been no public market for our common stock. Add to Watchlist. N/A. BERWYN, PA / ACCESSWIRE / April 5, 2021 / Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain managem... 2 months ago - Accesswire Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur (TM) for Postoperative Pain The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings. The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. (VRPX) raised $15 million in an initial public offering (IPO) on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO. No news for VRPX. It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) said it priced an underwritten public offering of 33.33 million shares of common stock at a public offering price of … Virpax Pharmaceuticals, Inc. Form S-1/A. Virpax Pharmaceuticals' lock-up period expires on Monday, August 16th. Virpax Pharmaceuticals had issued 1,800,000 shares in its initial public offering on February 17th. The total size of the offering was $18,000,000 based on an initial share price of $10.00. Founded Date 2017; Founders Anthony P Mack, Jeffrey Gudin; Operating Status Active; Last Funding Type Series C; Also Known As VRPX; Legal Name Virpax Pharmaceuticals Inc; Stock Symbol NASDAQ:VRPX ; Company Type For Profit; Contact Email … (Note: Virpax Pharmaceuticals upsized its IPO at pricing on Feb. 16, 2021, to 1.8 million shares, up from 1.36 million, at $10, the low end of its $10-to-$12 range, to raise $18 million.) Their stock opened with $10.00 in its Feb 16, 2021 IPO. $4.3301. Nasdaq 100. ACCESSWIRE +5.74%. Page 2 (ii) Upon the closing of Company’s initial public offering (“IPO”), Company shall pay to Contractor a lump sum amount equal to Six Thousand U.S. S-1. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. “We successfully completed our initial public offering (IPO) of 1,800,000 shares of our common stock in mid-February and immediately began our IND enabling … Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ: VRPX ), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of an animal study model for MMS019, its anti-viral product candidate for respiratory viruses. Their latest funding was raised on Feb 16, 2021 from a Series C round. 10/09/2020. SEC Filings provided by EDGAR Online, Inc. Prev Page Next Page. Not yet an official IPO, it's one of the first steps of taking a private company public. Data is currently not available. Virpax Pharmaceuticals, Inc. Country: United States: IPO Date: Feb 17, 2021: Industry: Biotechnology: Sector: Healthcare: Employees: 2: CEO: Anthony Mack WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for … Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, a Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is registered under the ticker NASDAQ:VRPX. Form S-1/A filed by Virpax Pharmaceuticals, Inc. with the security and exchange commission. Feb 22, 2021 Oscar Health Could Raise $1 Billion in IPO Next Week. 10/09/2020. Virpax Pharmaceuticals, Inc. May 1, 2020. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change. Industry: Pharmaceuticals: Employees: 2: Founded: 2017: Contact Information: Address: 1554 Paoli Pike, #279 West Chester, PA 19380: Phone Number (484) 880-4588: Web Address DGAP-News: Virpax(R) Pharmaceuticals Inc. / Key word(s): IPO 19.02.2021 / 22:07 The issuer is solely responsible for the content of this announcement. Exhibit 10.6 . Get Virpax Pharmaceuticals Inc historical price data for VRPX stock. Barron's Online. Virpax Pharmaceuticals, Inc. engages in developing pharmaceutical products for pain management by using new drug delivery systems. Virpax Pharmaceuticals is committed to developing products that manage pain and all its complexities, while minimizing risks to patients and society. Claim your 1-week free trial to StreetInsider Premium here. Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. SEC Filings for Virpax Pharmaceuticals Inc. Its products include DSF100, Probudur, Epoladerm and NES100. This Consulting Agreement (the “Agreement”) is entered into as of March 11, 2020 (the “Effective Date”), by and between Virpax Pharmaceuticals, Inc., a Delaware corporation, located at 101 Lindenwood Drive, Suite 225, Malvern, PA 19355 (“Virpax”), and Gerald W. Bruce, located at [***] (“Consultant”). Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. documents---0.0012590885162354. What we know about the Virpax Pharmaceuticals IPO. ThinkEquity (a division of Fordham Financial Management) served … Ticker: VRPX. BERWYN, Pa.-- (BUSINESS WIRE)-- #pharma -- Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. 19.02.2021 - DGAP-News: Virpax(R) Pharmaceuticals Inc. / Key word(s): IPO Virpax Pharmaceuticals Announces Closing of Initial Public Offering 19.02.2021 / 22:07 The issuer is … (VRPX) raised $15 million in an initial public offering (IPO) on Wednesday, February 17th 2021. IPO Data; IPO Date: 02/16/2021: Offer Price: $10.00: Price Range $10.00 - $12.00: Offer Shares (mm) 1.8: Deal Size ($mm) $18: Lock-Up Date: IPO Pro Only: Street Research: IPO Pro Only Virpax Pharma prices 1.8M-share IPO at $10. Virpax Pharmaceuticals filed a draft registration with the US Securities and Exchange Commission under the ticker symbol VRPX. When did Virpax Pharmaceuticals IPO? Virpax Pharmaceuticals (VRPX) has filed to raise $15 million in an IPO of its common stock, We anticipate that the initial public offering price of our common stock will be between $ 10.00. and $ 12.00. per share. Virpax Pharmaceuticals Announces Closing of Initial Public Offering. February 16, 2021. Feb. 17, 2021 3:15 AM ET Virpax Pharmaceuticals, Inc. (VRPX) By: Mamta Mayani, SA News Editor. One share of VRPX stock can currently be purchased for approximately $3.97. How much money does Virpax Pharmaceuticals make? Virpax Pharmaceuticals has a market capitalization of $19.63 million. +0.2801 (+6.92%) DATA AS OF Jun 16, 2021 11:14 AM ET. ET Virpax Announces Results of Probudur (TM) in … Virpax Pharmaceuticals Inc., a company specializing in developing pharmaceutical products for pain management, today announced the closing of its initial public offering … Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Nasdaq Listed. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $18.0 … Virpax Pharmaceuticals, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Apr 5, 2021 9:15 a.m. Our proprietary delivery systems will reinvent how patients and prescribers manage pain worldwide. The Historical Biotech IPO Database below tracks most listings over at least … BERWYN, Pa.-- ( BUSINESS WIRE )-- Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments.

Operation Simpsons Commercial, Bonnie And Clyde The Musical Cast, Ethernet Address In Wireshark, North Hollywood Homeless Problem, Portugal Proliga Standings, Bismarck Youth Hockey, Shallowater Chivalry Assignment, Data Science Projects For High School Students, Tcp Spurious Retransmission,